Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating lupus by administering humanized anti-CXCR5 (C-X-C motif chemokine receptor 5) antibodies

Method of treating lupus by administering humanized anti-CXCR5 (C-X-C motif chemokine receptor 5) antibodies

US Patent 10842869 · Granted Nov 24, 2020

Estimated economic value: $8,264,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Method of diagnosis and treatment of rheumatoid arthritis2025
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Detection of end-to-end transport quality2019
Methods for treating or preventing asthma by administering an IL-4R antagonist2017
Detection of end-to-end transport quality2016
Detection of end-to-end transport quality2014
System and method for processing and presenting internet usage information2003
Intrusion detection fence with trip wires and common actuator2003